SCHEMBL13259209

SCHEMBL13259209

OCCn1c(CCI)nc2cc(Cl)ccc21

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.63
NUDT1 P36639 1/20 0.53
BACE1 P56817 1/20 0.53
KDM4E B2RXH2 3/20 0.45
TBXA2R P21731 2/20 0.42
HDAC1 Q13547 1/20 0.42
JAK2 O60674 3/20 0.41
JAK1 P23458 3/20 0.41
TYK2 P29597 3/20 0.41
JAK3 P52333 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTT P42858 1/20 0.41
PDE10A Q9Y233 1/20 0.40
HPGD P15428 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40
MAT2A P31153 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7885451 0.87 KMT2A (0.62) KMT2ANUDT1BACE1KDM4ETBXA2R
SCHEMBL10176976 0.87 KMT2A (0.66) KMT2ANUDT1BACE1KDM4ETBXA2R
SCHEMBL27866490 0.80 KMT2A (0.53) KMT2ANUDT1BACE1KDM4ETBXA2R
SCHEMBL7260548 0.78 KMT2A (1.00) KMT2ANUDT1BACE1KDM4EHTT
SCHEMBL10177398 0.77 MAPT (0.51) KMT2ANUDT1BACE1TBXA2RHDAC1
SCHEMBL23100636 0.76 BACE1 (0.63) KMT2ANUDT1BACE1KDM4ETBXA2R
SCHEMBL11201306 0.76 BACE1 (0.67) KMT2ANUDT1BACE1TBXA2RHDAC1
SCHEMBL418587 0.75 GNRHR (0.50) KMT2AKDM4ETBXA2RSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL11385604 0.74 PDE10A (0.50) KMT2ANUDT1BACE1KDM4EJAK2
Hydrochloric Acid SCHEMBL11385601 0.74 PDE10A (0.50) KMT2ANUDT1BACE1KDM4EJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093425-A1 HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF SEPRACOR INC. (US) 2010-08-19 WO disclosed